biote Corp. (BTMD) stock
BTMDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$1.06+0.03 (+3.40%)
Close on Nov 13, 2026Market cap $38.26MP/E –Yield –
biote profit margin
Profit margin (net margin) is net income as a percentage of revenue.
biote's profit margin for the twelve months ending Sep 30, 2026 was -1.1%. For fiscal 2025 it was 14.1%, against 1.6% the year before. The highest annual figure on record is 14.1% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 14.1% | +12.5 |
| FY2024 | Dec 31, 2024 | 1.6% | −0.2 |
| FY2023 | Dec 31, 2023 | 1.8% | +2.4 |
| FY2022 | Dec 31, 2022 | -0.6% | −8.6 |
| FY2021 | Dec 31, 2021 | 8.0% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 0.9% | −16.1 |
| Q2 FY2026 | Jun 30, 2026 | -14.8% | −21.4 |
| Q1 FY2026 | Mar 31, 2026 | 5.1% | −22.9 |
| Q4 FY2025 | Dec 31, 2025 | 4.2% | −3.2 |
| Q3 FY2025 | Sep 30, 2025 | 17.1% | −3.8 |
| Q2 FY2025 | Jun 30, 2025 | 6.5% | +20.9 |
| Q1 FY2025 | Mar 31, 2025 | 28.0% | +36.9 |
| Q4 FY2024 | Dec 31, 2024 | 7.4% | −9.5 |
| Q3 FY2024 | Sep 30, 2024 | 20.8% | +4.3 |
| Q2 FY2024 | Jun 30, 2024 | -14.4% | −4.0 |
| Q1 FY2024 | Mar 31, 2024 | -8.9% | +6.3 |
| Q4 FY2023 | Dec 31, 2023 | 16.9% | +13.3 |
| Q3 FY2023 | Sep 30, 2023 | 16.5% | +16.5 |
| Q2 FY2023 | Jun 30, 2023 | -10.4% | −4.1 |
| Q1 FY2023 | Mar 31, 2023 | -15.2% | −18.3 |
| Q4 FY2022 | Dec 31, 2022 | 3.6% | +6.8 |
| Q3 FY2022 | Sep 30, 2022 | 0.0% | −8.4 |
| Q2 FY2022 | Jun 30, 2022 | -6.3% | −44.4 |
| Q1 FY2022 | Mar 31, 2022 | 3.2% | – |
| Q4 FY2021 | Dec 31, 2021 | -3.1% | – |
| Q3 FY2021 | Sep 30, 2021 | 8.4% | – |
| Q2 FY2021 | Jun 30, 2021 | 38.1% | – |
See a number that looks wrong?